BRT Apartments Corp. (MD) – Consensus Indicates Potential 24.4% Upside

DirectorsTalk Interviews

BRT Apartments Corp. (MD) found using ticker (BRT) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 32 and 26 with the average target price sitting at 28.25. Given that the stocks previous close was at 22.71 this would indicate that there is a potential upside of 24.4%. The 50 day MA is 23.16 and the 200 day moving average is 22.21. The company has a market capitalisation of $437m. You can visit the company’s website by visiting: https://www.brtapartments.com

The potential market cap would be $544m based on the market concensus.

BRT is a real estate investment trust that owns, operates and develops multi-family properties.

Share on:
Find more news, interviews, share price & company profile here for:

    Boku partners with Canva to boost access in Asia and Europe via localised payments

    Boku has announced a strategic partnership with Canva to expand the design platform’s reach across Asia and Europe through localised payment methods. The collaboration has already launched Vietnam’s MoMo digital wallet on Canva, with more integrations planned for 2025, aiming to make the platform more accessible in regions where card usage is low.

    Jubilee Metals to sell SA chrome and PGM assets for US$90m

    Jubilee Metals has issued a circular outlining plans to sell its Chrome and PGM Operations in South Africa to One Chrome (Pty) Ltd for up to US$90 million.

    Real Estate Credit Investments posts 2025 AGM circular

    Real Estate Credit Investments has issued its 2025 AGM circular and proxy form to shareholders. The meeting will take place on 17 September 2025 at East Wing, Trafalgar Court, St. Peter Port, Guernsey, with documents available via the National Storage Mechanism.

    Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

    Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis.

    Dekel Agri-Vision sees record cashew output, higher palm oil prices

    Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024.

    Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

    Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow

      Search

      Search